MediWound vs uniQure
MediWound reported revenue of $17 million in fiscal 2025, about the same as uniQure's $16 million in fiscal 2025. MediWound's revenue fell 16.1% in its latest year, and uniQure's fell 40.6%. MediWound had an operating margin of -149.0%, against -1151.4% at uniQure. Free cash flow was −$22 million at MediWound and −$178 million at uniQure.
Side by side
| MediWound | uniQure | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $17M | $16M |
| Revenue growth | −16.1% | −40.6% |
| Revenue growth a year, last 5 years | −4.9% | −15.6% |
| Gross margin | 19.2% | 89.5% |
| Operating margin | −149.0% | −1,151.4% |
| Net margin | −140.8% | −1,236.0% |
| Free cash flow | −$22M | −$178M |
| Free cash flow margin | −127.5% | −1,108.2% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 14.2% | 18.2% |
| Last close | $13.54 | $20.23 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | sold $19.8 million |
| Piotroski F-score | — | 2 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
MediWounduniQure
Operating margin
Percent of revenue
MediWounduniQure
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
MediWounduniQure
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the MediWound and uniQure pages.